In low-dose oral contraceptives containing 20 µg or 30 µg ethinylestradiol, gestodene is associated with a lower increase in coagulant factor VII than is desogestrel

K. W.M. Bloemenkamp*, J. A.Gevers Leuven, F. M. Helmerhorst, M. C. Dersjant-Roorda, R. de Boer, P. Meyer, D. Spielnrann, C. Kluft

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)145-148
Number of pages4
JournalGynecological Endocrinology
Issue numbersup2
Publication statusPublished - 1 Jan 1996


  • Ethinylestradiol
  • Factor VII
  • Oral Contraceptives
  • Thrombosis

Cite this